GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, PTGES, SRC, TYR |
9.06815 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGES, TBXAS1, TRPV1 |
9.06815 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MAOA, MET, MTNR1B, PPARA, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
8.38138 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, IGF1R, PPARA, PTGES, SRC, TRPV1, TYR |
7.92012 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.77134 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, PPARA, PTGES, SRC, TRPV1, TYR |
7.59404 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, NQO2, PIM1, PPARA, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
6.88572 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.6356 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.6356 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, PTGES, SRC, TRPV1, TYR |
6.56235 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, PPARA, PTGES, SRC, TERT, TRPV1, TYR |
6.52704 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOA, NQO2, TBXAS1, TYR, XDH |
6.22956 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
5.8746 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.42752 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, NQO2, PIM1, PPARA, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
5.37091 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
5.33282 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, SRC, TRPV1 |
5.29708 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, PTGES, SRC, TERT |
5.13333 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC, TERT, TRPV1, XDH |
4.79974 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MTNR1B |
4.74947 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.74687 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.68389 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TERT, TRPV1, XDH |
4.63012 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.36273 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MET, PPARA, PTGES, TBXAS1 |
4.26811 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.23045 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TRPV1 |
4.20007 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MTNR1A, PIM1, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
4.20007 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, CNR1, KDR, SRC, TNKS, TNKS2, TRPV1 |
4.18186 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HSD11B2, KDR, SRC, TRPV1 |
4.03646 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, IGF1R, KDR, PIM1, PTPN1, SRC, TERT, TRPV1, XDH |
4.03646 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, KDR, SRC |
3.90437 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, PIM1, PPARA, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
3.76408 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 |
3.7538 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MTNR1A, PIM1, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
3.67853 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, PIM1, PPARA, SRC, TERT, TNKS2, TYR |
3.67853 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 |
3.67842 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, PIM1, PTGES, SRC, TERT, XDH |
3.64979 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 |
3.63889 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MET, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.61813 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60561 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, KDR, MET, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.60561 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, PIM1, PPARA, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
3.60395 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.57503 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.57503 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MTNR1B, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.57503 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, IGF1R, KDR, MET, MTNR1B, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
3.48617 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, FLT3, MET, MTNR1B, SRC, TERT, TRPV1 |
3.42119 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, SRC |
3.38035 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.32045 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, MTNR1A, MTNR1B, PPARA, SRC |
3.31625 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.28887 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.22572 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2 |
3.22441 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KDR, MET, PIM1, PPARA, PTGES, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
3.22441 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, TBXAS1 |
3.22441 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, SRC |
3.22441 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.19113 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.15189 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, PIM1, PPARA, PTPN1, SRC, TERT |
3.12511 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, MAOA, TYR |
3.12032 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, TRPV1 |
3.09574 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, SRC, TERT, TRPV1 |
3.03826 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGES |
3.00188 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HSD11B2, SRC, TRPV1, TYR |
2.99778 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, IGF1R, MET, PIM1, PPARA, SRC, TNKS2, TRPV1, TYR |
2.95515 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, PIM1, PPARA, SRC, TYR |
2.95515 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, PIM1, PPARA, PTPN1, SRC, TNKS |
2.92883 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 |
2.87744 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.84508 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TERT |
2.83561 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.78464 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, PIM1, TERT |
2.78287 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.78287 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.78113 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, SRC, TRPV1 |
2.77664 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.7472 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, PPARA, PTGES, TBXAS1 |
2.7218 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.70377 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 |
2.68536 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TRPV1, TYR |
2.67422 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.62532 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.60453 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MTNR1A, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
2.60236 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.55935 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, MET, MTNR1B, TRPV1 |
2.55412 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.55412 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.53012 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.52944 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, KDR, SRC, TRPV1 |
2.51667 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.51081 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.51081 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.51026 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, IGF1R, KDR, PPARA, PTGES, PTPN1, SRC, TERT, TRPV1, TYR |
2.47023 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.44657 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, HSD11B2, SRC, TRPV1, TYR |
2.4391 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, KDR, MET, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.4391 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, FABP3, FLT3, HSD11B2, IGF1R, PPARA, SRC, TRPV1, TYR |
2.43584 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.43161 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KDR, MET, PIM1, PPARA, PTGES, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
2.42785 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.42668 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.42668 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MTNR1A, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
2.42002 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, IGF1R, KDR, MET, MTNR1A, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
2.41573 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, TRPV1 |
2.39098 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.38156 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, IGF1R, KDR, MET, PPARA, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.37801 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, MTNR1A, SRC |
2.37801 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, PPARA, SRC, TERT |
2.37068 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.3665 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.35057 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, KDR, MET, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.34623 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, KDR, SRC, TRPV1 |
2.34623 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, PIM1, PTPN1, SRC, TERT |
2.32857 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, AXL, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MTNR1B, PPARA, PTPN1, SRC, TERT, TRPV1 |
2.31993 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.31993 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.31806 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AXL, BCL2, CA1, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MTNR1A, MTNR1B, PIM1, PPARA, PTGES, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
2.30563 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.30563 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, FABP4, PTGES, TERT |
2.27605 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27319 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, SRC |
2.24479 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MTNR1A, PPARA, SRC, TERT, TNKS, TNKS2, TRPV1 |
2.22374 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.22374 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.20126 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.20126 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.20126 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.20126 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, TNKS, TNKS2 |
2.18872 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MAOA, SRC, XDH |
2.17343 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.15272 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, SRC |
2.14372 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.14372 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, PPARA, SRC, TERT, TNKS |
2.11671 |
[BP] GO:0032845 |
None
|
BCL2, SRC, TNKS, TNKS2, TRPV1 |
2.11074 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10287 |
[BP] GO:0080134 |
regulation of response to stress
|
CDK6, CNR1, CNR2, CYP19A1, ESR1, F3, FABP4, IGF1R, MET, PPARA, PTPN1, SRC, TERT, XDH |
2.10159 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, HSD11B2, IGF1R, PPARA, SRC, TRPV1 |
2.08109 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, ESR1, FLT3, SRC, TRPV1 |
2.06784 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.06375 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESR2, IGF1R, MET, PPARA, PTPN1, SRC, TERT, XDH |
2.03674 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.03505 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, MAOA, TYR |
2.03505 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.03112 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.03112 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.03112 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, PIM1, PPARA, PTGES, TBXAS1, TYR |
2.01337 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MAOA, MET, MTNR1A, MTNR1B, PIM1, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR |
2.78464 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MAOA, NQO2, PIM1, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
2.60247 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, TBXAS1 |
2.10494 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGES, PTPN1, TBXAS1 |
2.04927 |
[CC] GO:0044425 |
membrane part
|
ACHE, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MAOA, MET, MTNR1A, MTNR1B, PTGES, PTPN1, SRC, TBXAS1, TRPV1, TYR |
1.89985 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, NQO2, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TYR, XDH |
9.71425 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, NQO2, PIM1, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TYR, XDH |
8.49235 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.04772 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIM1, PPARA, PTGES, PTPN1, SRC, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
7.46793 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOA, NQO2, TBXAS1, TYR, XDH |
7.43711 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
5.24084 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.95364 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, NQO2, PTGES, SRC, TBXAS1, XDH |
4.95364 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.77133 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.26811 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.98985 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, NQO2, PIM1, PPARA, SRC, TRPV1 |
3.90045 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.81565 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.81565 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, NQO2, PIM1, PPARA, PTPN1, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
3.81127 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
3.78987 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, TRPV1 |
3.67853 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, NQO2, PPARA, PTPN1, TNKS |
3.67853 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.64979 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
3.57799 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, NQO2, PIM1, PPARA, PTPN1, TBXAS1, TERT, TNKS, TNKS2, TRPV1, TYR, XDH |
3.57503 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.57503 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.51395 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.48617 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.46375 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.4002 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
3.38035 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.36342 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 |
3.25437 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, CDK6, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
3.23066 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 |
3.1197 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.08267 |
[MF] GO:0042562 |
hormone binding
|
ACHE, HSD17B1, IGF1R, MTNR1A, NQO2 |
2.9524 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
2.87744 |
[MF] GO:0004872 |
receptor activity
|
AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
2.83991 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.78287 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.78287 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.78287 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.75914 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.5803 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.55339 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.5114 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, MTNR1A, MTNR1B, PPARA, TRPV1 |
2.436 |
[MF] GO:0008502 |
None
|
MTNR1A, MTNR1B |
2.42668 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.42668 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.41573 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.20126 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KDR, MET, NQO2, TERT, TRPV1, TYR, XDH |
2.18255 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.03112 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.01337 |